Liver fibrosis: pathological features, clinical treatment and application of therapeutic nanoagents

Lin Chen,Wenyan Guo,Chun Mao,Jian Shen,Mimi Wan

DOI: https://doi.org/10.1039/d3tb02790b

IF: 7.571

2024-01-13

Journal of Materials Chemistry B

Abstract:Liver fibrosis is a reversible damage-repair response, whose pathological features mainly include damage of hepatocytes, sinusoid capillarization, hepatic stellate cells (HSCs) activation, excessive accumulation of extracellular matrix (ECM) and inflammatory response. Although some treatments (including drugs and stem cell therapy) against these pathological features have been shown to be effective, more clinical trials are needed to confirm their effectiveness. In recent years, nanomaterials-based therapies have emerged as an innovative and promising alternative to traditional medicines, being explored for the treatment of liver fibrosis diseases. Natural nanomaterials (including extracellular vesicles) and synthetic nanomaterials (including inorganic nanomaterials and organic nanomaterials) are developed to facilitate drug targeting delivery and combination therapy. In this review, the pathological features of liver fibrosis and the current anti-fibrosis drugs in clinical trials are briefly introduced, followed by a detailed introduction of the therapeutic nanoagents for the precise delivery of anti-fibrosis drugs. Finally, the future development trend in this field is prospected.

materials science, biomaterials